In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.76 million shares were traded. DHC stock price reached its highest trading level at $3.6799 during the session, while it also had its lowest trading level at $3.5801.
Ratios:
For a better understanding of DHC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.88 and its Current Ratio is at 10.88. In the meantime, Its Debt-to-Equity ratio is 1.43 whereas as Long-Term Debt/Eq ratio is at 1.43.
On December 10, 2020, Wells Fargo Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’24 when Brown Matthew C. bought 2,000 shares for $2.55 per share. The transaction valued at 5,098 led to the insider holds 86,282 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 878747008 and an Enterprise Value of 3392178176. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.58 while its Price-to-Book (P/B) ratio in mrq is 0.47. Its current Enterprise Value per Revenue stands at 2.228 whereas that against EBITDA is 14.277.
Stock Price History:
The Beta on a monthly basis for DHC is 2.61, which has changed by 0.14106584 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $4.24, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is 3.47%, while the 200-Day Moving Average is calculated to be 29.64%.
Shares Statistics:
Over the past 3-months, DHC traded about 904.20K shares per day on average, while over the past 10 days, DHC traded about 705890 shares per day. A total of 241.42M shares are outstanding, with a floating share count of 216.87M. Insiders hold about 10.17% of the company’s shares, while institutions hold 77.76% stake in the company. Shares short for DHC as of 1753920000 were 5017251 with a Short Ratio of 5.55, compared to 1751241600 on 4912445. Therefore, it implies a Short% of Shares Outstanding of 5017251 and a Short% of Float of 4.04.
Dividends & Splits
DHC’s forward annual dividend rate is 0.04, up from 0.04 a year ago. Against a Trailing Annual Dividend Yield of 0.01098901The stock’s 5-year Average Dividend Yield is 2.25.
Earnings Estimates
The firm’s stock currently is rated by 1 analysts. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$0.59, with 1 analysts recommending between -$0.59 and -$0.59.
Revenue Estimates
1 analysts predict $377.04M in revenue for the current quarter. It ranges from a high estimate of $377.04M to a low estimate of $377.04M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $373.64MFor the next quarter, 1 analysts are estimating revenue of $379.69M. There is a high estimate of $379.69M for the next quarter, whereas the lowest estimate is $379.69M.
A total of 1 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.53B, while the lowest revenue estimate was $1.53B, resulting in an average revenue estimate of $1.53B. In the same quarter a year ago, actual revenue was $1.5BBased on 2 analysts’ estimates, the company’s revenue will be $1.58B in the next fiscal year. The high estimate is $1.6B and the low estimate is $1.56B.
